Clinical Development
Pipeline & Clinical
Trials
Clinical Development
Pipeline /
Clinical Trials
Advancing therapeutic acute wound care through clinical research
At AVITA Medical, we are dedicated to advancing patient-centered acute wound care. Through ongoing clinical research, we partner with clinicians to refine treatment protocols, explore innovative applications, and expand the evidence supporting our technologies.
This commitment to collaboration and discovery ensures that every solution we offer is grounded in rigorous scientific validation—delivering meaningful improvements to the lives of providers and patients alike.
Pipeline
| Concept | Research | Submission | Approval/ Clearance | Commercialization | |
|---|---|---|---|---|---|
| RECELL® & RECELL GO® (≤1920cm²) | |||||
| Deep Partial / Full-Thickness Burns | |||||
| Full-Thickness Traumatic Wounds | |||||
| Full-Thickness Surgical Wounds | |||||
| RECELL GO Mini™ (≤480cm²) | |||||
| Deep Partial / Full-Thickness Burns | |||||
| Full-Thickness Traumatic Wounds | |||||
| Full-Thickness Surgical Wounds | |||||
| COHEALYX® | |||||
| Partial-Thickness Burns | |||||
| Partial-Thickness Wounds (including donor sites) |
|||||
| Full-Thickness Wounds | |||||
| PERMEADERM® | |||||
| Partial-Thickness Burns | |||||
| Partial-Thickness Wounds (including donor sites) |
|||||
| Coverage of Meshed Autograft | |||||
| Temporary Coverage of Surgical Wounds |
Current clinical trials
PERMEADERM I: TEMPORARY COVERAGE OF SURGICAL WOUNDS
Click here for more information about eligibility and enrollment in AVITA Medical’s PermeaDerm I Clinical Study
“Randomized Controlled Trial to Investigate Clinical Outcomes and Associated Costs When PermeaDerm is Used as a Temporary Dressing for Surgical Wounds”
Study: NCT06750809 on clinicaltrials.gov
- This multicenter randomized controlled trial aims to compare PermeaDerm with human cadaveric allograft as a temporary wound covering for surgical wounds. The study will assess potential cost savings with PermeaDerm, as well as key clinical metrics such as time to graft readiness, wound healing, and hospital length of stay.
COHEALYX I: MANAGEMENT OF SURGICALLY EXCISED FULL-THICKNESS WOUNDS
Click here for more information about eligibility and enrollment in AVITA Medical’s Cohealyx I Clinical Study
“Multicenter Single-arm Trial to Investigate Clinical Outcomes When Cohealyx™ is Used for Full-Thickness Wounds”
Study: NCT06787690 on clinicaltrials.gov
- This post-market, multicenter, single-arm clinical study aims to further evaluate Cohealyx in preparing full-thickness wounds for definitive closure after surgical excision. The primary goal is to measure the time to skin graft readiness against a literature-derived benchmark. Additional measures include graft take, wound healing, and scar outcomes.
Information on this page is for the US only and does not apply internationally.